| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Jul-07 | | Total Revenue | 10,645 | 6,994 | 10,662 | | Cost of Revenue | 5,863 | 3,155 | 4,615 | | | Gross Profit | 4,782 | 3,839 | 6,047 | | | Operating Expenses | | Research Development | 926 | 2,641 | 2,872 | | Selling General and Administrative | 3,633 | 4,176 | 4,777 | | Non Recurring | 120 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 103 | (2,978) | (1,602) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 117 | 272 | | Earnings Before Interest And Taxes | 132 | (2,861) | (1,330) | | Interest Expense | 466 |
-
|
-
| | Income Before Tax | (334) | (2,861) | (1,330) | | Income Tax Expense | 5 |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (339) | (2,861) | (1,330) | | | Non-recurring Events | | Discontinued Operations |
-
| (591) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (339) | (3,452) | (1,330) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($339) | ($3,452) | ($1,330) |
|
1.48% Nasdaq 0.00%
Income Statement
